QuickLogic Corporation (NASDAQ:QUIK), the innovator of ultra-low-power Customer Specific Standard Products (CSSPs), announced the financial results for its fiscal first quarter ended March 30, 2014. QuickLogic Corporation (NASDAQ:QUIK), shares after opening at $3.86 moved to $3.86 on last trade day and at the end of the day closed at $3.68. Company price to sales ratio in past twelve months was calculated as 7.74 and price to cash ratio as 5.40. QuickLogic Corporation (NASDAQ:QUIK), showed a negative weekly performance of 25.51%.
Synthetic Biologics Inc (NYSEMKT:SYN), released that the University of California, Los Angeles (UCLA) School of Medicine declared preliminary, optimistic topline data from the Phase II clinical trial evaluating Trimesta (oral estriol), the Company’s oral, once-daily treatment for relapsing-remitting multiple sclerosis (RRMS) in women. Stocks of Synthetic Biologics Inc (NYSEMKT:SYN) plunged -27.84% to close at $2.10 with the total average volume of 1.50 million. Its market capitalization is $16.92 billion. Synthetic Biologics Inc (NYSEMKT:SYN), shares fell 9.41% in last trading session and ended the day on $1.30. Synthetic Biologics Inc (NYSEMKT:SYN), return on equity ratio is recorded as -115.80% and its return on assets is -110.30%. Synthetic Biologics Inc (NYSEMKT:SYN), yearly performance is -9.09%.
On April 30, 2014, ANADIGICS, Inc. (NASDAQ:ANAD), a leading provider of semiconductor solutions in the broadband wireless and wireline communications markets, reported first quarter 2014 net sales of $23.3 million, a decrease of 35.9% sequentially and 11.8% from the first quarter of 2013. ANADIGICS, Inc. (NASDAQ:ANAD), shares moved up 5.31% in last trading session and was closed at $1.19, while trading in range of $ 1.14 – 1.26. ANADIGICS, Inc. (NASDAQ:ANAD), year to date (YTD) performance is -35.33%.
On April 30, 2014, Brightcove Inc (NASDAQ:BCOV), a leading global provider of cloud services for video, announced financial results for the quarter ended March 31, 2014. Brightcove Inc (NASDAQ:BCOV), weekly performance is -0.13%. On last trading day company shares ended up $7.95. Brightcove Inc (NASDAQ:BCOV), distance from 50-day simple moving average (SMA50) is -17.05%. Analysts mean target Price for the company is $17.08.